Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies and Estimates (Details Textual)

v3.6.0.2
Summary of Significant Accounting Policies and Estimates (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Significant Accounting Policies [Line Items]      
Advertising costs $ 104 $ 25 $ 1
Debt Issuance Cost [Member] | Accounting Standards Update 2015-03 [Member]      
Significant Accounting Policies [Line Items]      
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets 95    
Medical Device [Member]      
Significant Accounting Policies [Line Items]      
Deferred Revenue, Revenue Recognized   6,517  
Cost of Revenue   $ 4,159  
Product Liability Accrual, Component Amount 212    
Customer Advances and Deposits, Current 911    
Reduction In Net Loss Attributable To Common Stock Holders $ 2,358    
Reduction Percentage In Net Loss Attributable To Common Stock Holders $ 0.13    
Sales Revenue, Net [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 10.00%    
Customer One [Member] | Accounts Receivable [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 18.00% 10.00% 22.00%
Customer One [Member] | Sales Revenue, Net [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage   33.00% 12.00%
Customer Two [Member] | Accounts Receivable [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 16.00%   11.00%
Customer Three [Member] | Accounts Receivable [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 11.00%    
Customer Concentration Risk [Member] | Accounts Receivable [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 10.00%